On the Brink of Change: How Academic Data and Machine Learning Can Revolutionize Alzheimer's Drug Development

White Paper

November 20, 2018
On the Brink of Change How Academic Data and Machine Learning Can Revolutionize Alzheimers Drug Deve

In this white paper, you will:

  • Hear about current industry challenges in Alzheimer’s drug development and glean insights as to why we must explore new clinical approaches
  • Understand the importance of machine learning and predictive analytics for identifying non-diagnosed prodromal Alzheimer’s disease patients—and why we must tap into this unexplored general population to bring about real advancement
  • Learn why innovative approaches to Alzheimer’s drug development are not only necessary, but how they will positively impact the future of Alzheimer’s disease for patients and the medical community alike